Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Details Added to Venturepharm Asia JV Plan

publication date: May 7, 2008

Venturepharm Asia, a joint venture between Commonwealth Biotechnologies and Venturepharm, will build two state-of-the-art chemistry facilities in Jiangsu province, China, with capital provided by Venturepharm and grants awarded by the federal government of China. The labs will employ 200 chemists by the end of 2008, and the JV expects to have 1000 scientists on board in 2010. The JV expects “strong” revenues in the first twelve months of operation, though it did not disclose a specific figure. It further projects that revenues will expand five-fold by 2010. More details...

Stock Symbols: (NSDQ: CBTE) (HK: 8225)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital